| Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) (NCT01336621) | GlaxoSmithKline | 2011-02-21 |
| Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years) (NCT01277042) | GlaxoSmithKline | 2011-02-17 |
| Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam (NCT01153841) | GlaxoSmithKline | 2011-02-17 |
| Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212 (NCT01387204) | GlaxoSmithKline | 2011-02-15 |
| An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation. (NCT01332513) | GlaxoSmithKline | 2011-02-10 |
| Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants (NCT01262872) | GlaxoSmithKline | 2011-02-09 |
| Risk of Urinary Retention With Retigabine (NCT01462656) | GlaxoSmithKline | 2011-02-01 |
| Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils (NCT01366521) | GlaxoSmithKline | 2011-02-01 |
| A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP)) (NCT01342913) | GlaxoSmithKline | 2011-02-01 |
| A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population (NCT01313663) | GlaxoSmithKline | 2011-02-01 |
| Effects of a Common Cold Treatment on Cognitive Function (NCT01466348) | GlaxoSmithKline | 2011-02-01 |
| A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain (NCT01266967) | GlaxoSmithKline | 2011-02-01 |
| Drug Use Investigation for XYZAL® (NCT01445262) | GlaxoSmithKline | 2011-02-01 |
| Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma (NCT01213472) | GlaxoSmithKline | 2011-01-31 |
| Bioequivalence Study of Cephalexin Suspension 125 (NCT01767532) | GlaxoSmithKline | 2011-01-30 |
| Bioequivalence Study of Cephalexin Suspension 250 (NCT01767571) | GlaxoSmithKline | 2011-01-30 |
| An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors (NCT01262963) | GlaxoSmithKline | 2011-01-26 |
| Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease (NCT01313676) | GlaxoSmithKline | 2011-01-25 |
| The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study (NCT01249365) | GlaxoSmithKline | 2011-01-24 |
| Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors (NCT01324258) | GlaxoSmithKline | 2011-01-24 |
| Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults (NCT01262976) | GlaxoSmithKline | 2011-01-17 |
| A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza (NCT01231620) | GlaxoSmithKline | 2011-01-15 |
| Bioequivalence Study of 300 mg Gabapentin (NCT01738893) | GlaxoSmithKline | 2011-01-14 |
| A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects (NCT01332552) | GlaxoSmithKline | 2011-01-14 |
| Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants (NCT01231503) | GlaxoSmithKline | 2011-01-13 |
| An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects (NCT01267968) | GlaxoSmithKline | 2011-01-11 |
| Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males (NCT01428479) | GlaxoSmithKline | 2011-01-07 |
| SAP Depleter Dose Escalation Study in Healthy Volunteers (NCT01323985) | GlaxoSmithKline | 2011-01-06 |
| A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin (NCT01411111) | GlaxoSmithKline | 2011-01-06 |
| Efficacy and Safety of Ambrisentan in Children 8-18yrs (NCT01332331) | GlaxoSmithKline | 2011-01-04 |
| Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children (NCT01266993) | GlaxoSmithKline | 2011-01-03 |
| A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers (NCT01039909) | GlaxoSmithKline | 2011-01-01 |
| Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure (NCT01045564) | GlaxoSmithKline | 2011-01-01 |
| A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01316887) | GlaxoSmithKline | 2011-01-01 |
| Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure (NCT01277679) | GlaxoSmithKline | 2011-01-01 |
| A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma (NCT01227889) | GlaxoSmithKline | 2010-12-23 |
| A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. (NCT01466322) | GlaxoSmithKline | 2010-12-22 |
| Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (NCT01294592) | GlaxoSmithKline | 2010-12-22 |
| A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease (NCT01277666) | GlaxoSmithKline | 2010-12-20 |
| A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers (NCT01258530) | GlaxoSmithKline | 2010-12-20 |
| Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension) (NCT01406327) | GlaxoSmithKline | 2010-12-14 |
| Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus (NCT01251744) | GlaxoSmithKline | 2010-12-09 |
| A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children (NCT01218308) | GlaxoSmithKline | 2010-12-09 |
| Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) (NCT01248884) | GlaxoSmithKline | 2010-12-09 |
| Bioequivalence Trial of Alprazolam 0.5 mg Tablets (NCT01745562) | GlaxoSmithKline | 2010-12-07 |
| Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia (NCT01094171) | GlaxoSmithKline | 2010-12-03 |
| Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors. (NCT01248858) | GlaxoSmithKline | 2010-12-03 |
| A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (NCT01254019) | GlaxoSmithKline | 2010-12-02 |
| Bioequivalence Trial of Alprazolam 0.25 mg Tablets (NCT01853956) | GlaxoSmithKline | 2010-12-02 |
| Cardiovascular and Torsades de Pointes Monitoring for Pazopanib (NCT01446224) | GlaxoSmithKline | 2010-12-01 |
| A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1) (NCT01245426) | GlaxoSmithKline | 2010-12-01 |
| Special Drug Use Investigation for ALLERMIST (Long Term) (NCT01420822) | GlaxoSmithKline | 2010-12-01 |
| Physician Liver Function Test (LFT) Monitoring for Tykerb Pts (NCT01462552) | GlaxoSmithKline | 2010-12-01 |
| A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01319019) | GlaxoSmithKline | 2010-12-01 |
| Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study (NCT01424527) | GlaxoSmithKline | 2010-12-01 |
| Hepatic Monitoring for Pazopanib (NCT01449825) | GlaxoSmithKline | 2010-12-01 |
| SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis (NCT01424514) | GlaxoSmithKline | 2010-12-01 |
| Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma (NCT01248975) | GlaxoSmithKline | 2010-12-01 |
| Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer (NCT01205217) | GlaxoSmithKline | 2010-12-01 |
| Drug Use Investigation for AVOLVE(BPH) (NCT01376284) | GlaxoSmithKline | 2010-12-01 |
| A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo (NCT01299610) | GlaxoSmithKline | 2010-12-01 |
| Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea (NCT01248988) | GlaxoSmithKline | 2010-12-01 |
| Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years (NCT01235975) | GlaxoSmithKline | 2010-11-30 |
| Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old (NCT01236040) | GlaxoSmithKline | 2010-11-29 |
| FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers (NCT01294566) | GlaxoSmithKline | 2010-11-29 |
| Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain (NCT01592799) | GlaxoSmithKline | 2010-11-23 |
| Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus (NCT01222078) | GlaxoSmithKline | 2010-11-22 |
| GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma (NCT01245062) | GlaxoSmithKline | 2010-11-22 |
| Japanese Phase 1 Study of GSK2585823 (NCT01428466) | GlaxoSmithKline | 2010-11-18 |
| A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment. (NCT01266980) | GlaxoSmithKline | 2010-11-18 |
| Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment (NCT01235949) | GlaxoSmithKline | 2010-11-12 |
| Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth. (NCT01198769) | GlaxoSmithKline | 2010-11-11 |
| Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons (NCT01218113) | GlaxoSmithKline | 2010-11-08 |
| Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil) (NCT01376232) | GlaxoSmithKline | 2010-11-08 |
| Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old (NCT01267006) | GlaxoSmithKline | 2010-11-05 |
| Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD). (NCT01218126) | GlaxoSmithKline | 2010-11-04 |
| A Pivotal Study to Assess the Effectiveness of Nasal Dilator (Breathe Right Nasal Strips) (NCT03549130) | GlaxoSmithKline | 2010-11-04 |
| A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients. (NCT01277692) | GlaxoSmithKline | 2010-11-03 |
| Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population (NCT01615783) | GlaxoSmithKline | 2010-11-01 |
| GSK2190915 Pediatric Study (NCT01286844) | GlaxoSmithKline | 2010-11-01 |
| A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data (NCT01381523) | GlaxoSmithKline | 2010-11-01 |
| Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma (NCT01328106) | GlaxoSmithKline | 2010-11-01 |
| Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim (NCT01439321) | GlaxoSmithKline | 2010-11-01 |
| Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia (NCT01231607) | GlaxoSmithKline | 2010-10-28 |
| Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females (NCT01031069) | GlaxoSmithKline | 2010-10-26 |
| Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. (NCT01494610) | GlaxoSmithKline | 2010-10-25 |
| A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan) (NCT03549117) | GlaxoSmithKline | 2010-10-25 |
| Phase I Study of Colistin Methanesulfonate Sodium (NCT01449838) | GlaxoSmithKline | 2010-10-23 |
| An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor (NCT01231568) | GlaxoSmithKline | 2010-10-21 |
| A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment. (NCT01266941) | GlaxoSmithKline | 2010-10-18 |
| 3 Month PHI PAD PoM Study (NCT02135848) | GlaxoSmithKline | 2010-10-15 |
| A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate. (NCT01160198) | GlaxoSmithKline | 2010-10-13 |
| Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers (NCT01431937) | GlaxoSmithKline | 2010-10-10 |
| A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects (NCT01262885) | GlaxoSmithKline | 2010-10-07 |
| Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM (NCT01190215) | GlaxoSmithKline | 2010-10-04 |
| Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria (NCT01153893) | GlaxoSmithKline | 2010-10-04 |
| Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children (NCT01196988) | GlaxoSmithKline | 2010-10-04 |
| Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A) (NCT01204671) | GlaxoSmithKline | 2010-10-04 |
| Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler (NCT01213849) | GlaxoSmithKline | 2010-10-04 |
| Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination (NCT01153906) | GlaxoSmithKline | 2010-10-01 |